Illtroductioll
Specific gene rearrangements are considered to be a characteristic clonal marker of tumor cells. These genetic events seem to be involved in tumor development and, moreover, the discovery of molecular changes has generated new possibilities for diagnosis and follow-up monitoring ofleukemic patients. In this chapter we describe a rapid and simple clonal assay for the quantification of blast cells using a recently detected gene rearrangement associated with T-cell lymphoblastic leukemia, named tal-l deletion [1, 2] .
Patients and Methods
We have studied five patients with T-cell acute lymphoblastic leukemia bearing a deletion in the tal-l gene, which had been detected by routine screening of 56 heparinized bone marrow samples as described previously [3] . Total cellular DNA was extracted by standard methods using Quiagen 20 columns (Diagen, Dusseldorf, Germany) according to the manufactures protocol. Five percent of the final amount of DNA was subjected to a nested polymerase chain reaction, which was carried out in a Biomed 60 thermal cycler (Biomed, Theres, Germany). To facilitate cloning Sal I and BcI I recognition sites were added to the 5' end of the PCR primers. After cloning in a pUC 19 vector DNA sequencing was done by dideoxy chain termination [4] . To rule out any Children's Hospital, University of GieBen, Germany PCR or cloning artefacts two different clones from each bone marrow sample were sequenced.
To quantify the copy number of the rearranged tal-l gene in these bone marrow samples 10000 copies of an internal standard probe were added to a dilution series of bone marrow DNA and co amplified by PCR. The DNA sequence of the internal standard probe was identical to the deleted tal-l gene sequence, except for 5-10 mismatches within the fusion region. After 35 cycles of PCR amplification 2 ng of the internal standard probe labeled with 32p dCTP were added and a denaturation/renaturation step (2 min 98°C, 60 min 70°C, 30 min 65°C) was carried out to form heteroduplexes between the standard and the target sequences. The hetero-and homo duplexes were separated on an 8% polyacrylamide gel run homogeneously at lOoC in a temperature gradient gel electrophoresis (TGGE) apparatus (Diagen). Under these gel conditions heteroduplexes run much slower than homo duplexes due to loop-out effects of non-matched DNA-regions. After fixation with 10% acetic acid the gel was covered with a Kodak XAR5 X-ray film and exposed for 2-3 h. The template copy number was calculated by the ratio between template and standard intensity.
Results
In five out of the 56 (9%) patients with T-cell ALL a specific tal recombination site was detected by PCR. One patient was investigated at diagnosis and at relapse 11 months later. The nucleotide sequence of the fusion site was identical in both bone marrow samples. All nucleotide sequences ofthe tal-l rearrangement Fig. 2 . Quantitative assay to determine the deleted tal-l gene copy number in a bone marrow sample from patient no. 4. DNA from this bone marrow sample was diluted serially by tenfold. Lane 1, the highest; lane 6, the lowest concentration of the template DNA. 10000 copies of a tal-I standard were added to each probe prior to PCR amplification. Note the increasing intensity of homoduplexes and the decreasing signals of heteroduplexes in lower template concentrations. The copy number of deleted tal-I genes in the patient's bone marrow sample can be calculated by the equation: heteroduplex intensity/homoduplex intensity x number of initial standard copies = initial template number (in lane 1, for example, it is about 30000)
